Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays by Nesbitt A, Fossati G

Climate resilience in the United Kingdom wine production sector: CREWS-UK by Nesbitt A., Dorling S., Jones R.

Get full text

Curing of polymeric composites using microwave resin transfer moulding (RTM) by Yusoff, R., Aroua, M.K., Nesbitt, A., Day, R.J.

Get full text

The in vivo and in vitro characterisation of an engineered human antibody to E-selectin. by Owens, R, Ball, E, Ganesh, R, Nesbitt, A, Brown, D, Gofton, C, Stephens, S, Chaplin, L, Christofidou-Solomidou, M, Blake, S, Howat, D, Buurman, W, Albelda, S, Robinson, M